Rapid Communication
Copyright ©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2007; 13(43): 5736-5740
Published online Nov 21, 2007. doi: 10.3748/wjg.v13.i43.5736
Table 1 Characteristics at baseline of chronic hepatitis C patients infected by substance use in a Belgian population eligible for treatment in a randomised trial
Characteristics at baselinenThrice in wk 3 MIU interferonWeekly pegylated interferonTotalWilcoxon rank sum test or fishers exact test
Age at baseline (yr)493737370.99
At exposure (yr)492728270.55
At infection (yr)493336350.58
Body mass index332525250.93
Genotype (%)
-non 2-3257336530.02a
-522276447
Gender (%)
F112619220.73
M38748178
Methadone user (%)493935370.77
Drug user active (%)485954560.77
IVDU (%)499192921.00
Activity1
A0 + 1408196890.17
A2 + 3519411
Fibrosis1
F0 + 1203850440.19
F2 + 322485049
-F431407
Steatosis1
S0204052470.73
S112302628
S2 + 311302226
ASAT at baseline (IU/L)495977680.2098
ALAT at baseline (IU/L)49871271080.0635